Jul 20, 2020
3:2
For every 2 shares held, investors received 3. The price per share adjusted from $1.75 to $1.17.
The split itself did not change the total investment value.
Sino Biopharmaceutical Limited (GETTEX:SMZ1) operates in the Pharmaceuticals: major industry.
Sino Biopharmaceutical Limited company overviewSino Biopharmaceutical Limited's most recent stock split was on July 20, 2020. It was a 3-for-2 forward split, so shareholders received 3 shares for every 2 they held.
Sino Biopharmaceutical Limited (GETTEX:SMZ1) has split its stock 7 times: a 4-for-1 split on April 28, 2004, a 3-for-2 split on May 6, 2005, a 4-for-3 split on June 3, 2009, a 3-for-2 split on December 4, 2009, a 3-for-2 split on November 13, 2015, a 3-for-2 split on June 4, 2018, and a 3-for-2 split on July 20, 2020.
Sino Biopharmaceutical Limited has split its stock 7 times. This history records 7 forward splits between April 28, 2004 and July 20, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Sino Biopharmaceutical Limited's 3-for-2 split on July 20, 2020, every 2 shares became 3 shares.
Sino Biopharmaceutical Limited has not announced a new split in our records. Its most recent split was on July 20, 2020, 6 years ago. Companies announce splits in advance, and any new GETTEX:SMZ1 split will appear on this page.
Already premium?